This inventor holds 3 USPTO granted patents and 13 published patent applications and 1 EPO patent. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Marine Kraus: Innovator in Hepatic Health Solutions
Introduction
Marine Kraus is a notable inventor based in Vuarrens, Switzerland. She has made significant contributions to the field of hepatic health through her innovative research and patented inventions. With a total of 3 patents, her work focuses on developing compositions and methods that address liver-related diseases.
Latest Patents
Kraus's latest patents include groundbreaking formulations aimed at treating or preventing nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatitis, and hepatic steatosis. One of her notable inventions involves a formulation that combines at least one glycine or its derivative, N-acetylcysteine or its derivative, and thymol or carvacrol. This formulation is designed to effectively decrease liver steatosis and concomitantly reduce liver damage, particularly in patients suffering from NAFLD. Another patent focuses on the production of brown adipocytes using a transforming growth factor beta (TGF-β) signaling inhibitor, showcasing her innovative approach to cellular health.
Career Highlights
Marine Kraus is associated with Société des Produits Nestlé S.A., where she continues to advance her research in the field of health and nutrition. Her work has garnered attention for its potential impact on treating liver diseases, making her a key figure in the industry.
Collaborations
Kraus has collaborated with esteemed colleagues such as Stephen Dalton and John W. Avery, III, further enhancing the scope and impact of her research.
Conclusion
Marine Kraus stands out as an influential inventor in the realm of hepatic health solutions. Her innovative patents and ongoing research contribute significantly to the understanding and treatment of liver diseases.